UB Paderborn / Katalog / Suche / in CDI

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

British journal of cancer, 2006-05, Vol.94 (10), p.1361-1368

2006

Volltextzugriff (PDF)

EE378 Targeted Literature Review of Non-Payer Costing in Societal-Perspective Oncology Cost Effectiveness Models

Value in health, 2023-06, Vol.26 (6), p.S128-S128

2023

Volltextzugriff (PDF)

Indirect Cost Burden Attributable to Locally Advanced Head and Neck Squamous Cell Carcinoma in the United States

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e295-e296

2022

Volltextzugriff (PDF)

PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a Problem

Value in health, 2012-11, Vol.15 (7), p.A541-A542

2012

Volltextzugriff (PDF)

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

European urology, 2008-09, Vol.54 (3), p.543-562

2008

Volltextzugriff (PDF)

EE231 Calculating the Indirect Cost of Disease Recurrence and Subsequent Premature Mortality in Patients Diagnosed with Early-Stage Hepatocellular Carcinoma (HCC) in the United States (US)

Value in health, 2022-07, Vol.25 (7), p.S379

2022

Volltextzugriff (PDF)

Budget Impact of Keytruda for the Treatment of Patients with Recurrent or Metastatic (R/M) and Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC) in the United States

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e55-e55

2022

Volltextzugriff (PDF)

EE673 Cost-Effectiveness Analysis of Pembrolizumab for First-Line Treatment in Patients With Persistent, Recurrent, and Metastatic Cervical Cancer in the United States: Results From the Final Analysis of Trial

Value in health, 2023-12, Vol.26 (12), p.S183

2023

Volltextzugriff (PDF)

PCN72 Biomarker Testing to Guide Cost Effective Use of PARPi in Patients with Newly Diagnosed Ovarian Cancer

Value in health, 2020-12, Vol.23, p.S434-S434

2020

Volltextzugriff (PDF)

PT33 Cost-Effectiveness of Pembrolizumab Plus Chemotherapy, With or Without Bevacizumab for the First-Line Treatment of PD-L1-Positive Patients With Persistent, Recurrent, or Metastatic Cervical Cancer in France

Value in health, 2023-12, Vol.26 (12), p.S201

2023

Volltextzugriff (PDF)

PCN70 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN METASTATIC PANCREATIC CANCER: A SYSTEMATIC LITERATURE REVIEW

Value in health, 2020-05, Vol.23, p.S35-S35

2020

Volltextzugriff (PDF)

622P Exploring the impact of treatment switching on the interim overall survival (OS) results of the PROfound study

Annals of oncology, 2020-09, Vol.31, p.S514-S514

2020

Volltextzugriff (PDF)

PCN96 US COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO REGORAFENIB AND CABOZANTINIB IN SECOND LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA

Value in health, 2019-05, Vol.22, p.S73-S74

2019

Volltextzugriff (PDF)

PCN107 COST COMPARISON OF ADVERSE EVENT MANAGEMENT WITH POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS (PARPI) IN THE MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER

Value in health, 2020-05, Vol.23, p.S42-S42

2020

Volltextzugriff (PDF)

A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

Value in health, 2016-11, Vol.19 (7), p.A562-A562

2016

Volltextzugriff (PDF)

PSS4 - A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

Value in health, 2016-11, Vol.19 (7), p.A562-A562

2016

Volltextzugriff (PDF)

PMC21 COST-EFFECTIVENESS SENSITIVITY TO COST-EFFECTIVENESS CORRELATION: A SIMULATION STUDY

Value in health, 2008, Vol.11 (3), p.A175-A175

Muston, D

2008

Volltextzugriff (PDF)

An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data

BMC ophthalmology, 2018-12, Vol.18 (1), p.340-340, Article 340

2018

Volltextzugriff (PDF)

PHP34 EXAMINING INCENTIVES FOR SUBGROUPING IN NICE SUBMISSIONS

Value in health, 2007, Vol.10 (6), p.A371-A371

Muston, D

2007

Volltextzugriff (PDF)

PMC8 SYSTEMATIC REVIEW RELIABILITY: EFFICACY OF TWO INDEPENDENT REVIEWERS AND TWO-STEP REVIEWS

Value in health, 2009, Vol.12 (3), p.A21-A21

2009

Volltextzugriff (PDF)

PMC63 SYSTEMATIC REVIEW RELIABILITY: SENSITIVITY AND SPECIFICITY OF ONEVS.TWO REVIEWS

Value in health, 2008, Vol.11 (6), p.A578-A579

2008

Volltextzugriff (PDF)

PSS24 SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS REGARDING THE COMPARATIVE INCIDENCE OF HYPERAEMIA OF PROSTAGLANDIN TOPICAL GLAUCOMA MEDICATIONS

Value in health, 2008, Vol.11 (6), p.A616-A617

2008

Volltextzugriff (PDF)

PSS4 COST EFFECTIVENESS ANALYSIS OF THE ACRYSOF CACHET PHAKIC INTRAOCULAR LENS

Value in health, 2010, Vol.13 (3), p.A146-A146

2010

Volltextzugriff (PDF)

PHP68 CHARACTERISTICS OF RISK-SHARING SCHEMES IN EUROPE

Value in health, 2008, Vol.11 (3), p.A49-A49

2008

Volltextzugriff (PDF)

PCN96 COLORECTAL CANCER SCREENING: COST-EFFECTIVENESS OF CT COLONOGRAPHY

Value in health, 2009, Vol.12 (7), p.A275-A275

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

EE378 Targeted Literature Review of Non-Payer Costing in Societal-Perspective Oncology Cost Effectiveness Models

Indirect Cost Burden Attributable to Locally Advanced Head and Neck Squamous Cell Carcinoma in the United States

PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a Problem

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

EE231 Calculating the Indirect Cost of Disease Recurrence and Subsequent Premature Mortality in Patients Diagnosed with Early-Stage Hepatocellular Carcinoma (HCC) in the United States (US)

Budget Impact of Keytruda for the Treatment of Patients with Recurrent or Metastatic (R/M) and Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC) in the United States

EE673 Cost-Effectiveness Analysis of Pembrolizumab for First-Line Treatment in Patients With Persistent, Recurrent, and Metastatic Cervical Cancer in the United States: Results From the Final Analysis of Trial

PCN72 Biomarker Testing to Guide Cost Effective Use of PARPi in Patients with Newly Diagnosed Ovarian Cancer

PT33 Cost-Effectiveness of Pembrolizumab Plus Chemotherapy, With or Without Bevacizumab for the First-Line Treatment of PD-L1-Positive Patients With Persistent, Recurrent, or Metastatic Cervical Cancer in France

PCN70 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN METASTATIC PANCREATIC CANCER: A SYSTEMATIC LITERATURE REVIEW

622P Exploring the impact of treatment switching on the interim overall survival (OS) results of the PROfound study

PCN96 US COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO REGORAFENIB AND CABOZANTINIB IN SECOND LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA

PCN107 COST COMPARISON OF ADVERSE EVENT MANAGEMENT WITH POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS (PARPI) IN THE MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER

A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

PSS4 - A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

PMC21 COST-EFFECTIVENESS SENSITIVITY TO COST-EFFECTIVENESS CORRELATION: A SIMULATION STUDY

An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data

PHP34 EXAMINING INCENTIVES FOR SUBGROUPING IN NICE SUBMISSIONS

PMC8 SYSTEMATIC REVIEW RELIABILITY: EFFICACY OF TWO INDEPENDENT REVIEWERS AND TWO-STEP REVIEWS

PMC63 SYSTEMATIC REVIEW RELIABILITY: SENSITIVITY AND SPECIFICITY OF ONEVS.TWO REVIEWS

PSS24 SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS REGARDING THE COMPARATIVE INCIDENCE OF HYPERAEMIA OF PROSTAGLANDIN TOPICAL GLAUCOMA MEDICATIONS

PSS4 COST EFFECTIVENESS ANALYSIS OF THE ACRYSOF CACHET PHAKIC INTRAOCULAR LENS

PHP68 CHARACTERISTICS OF RISK-SHARING SCHEMES IN EUROPE

PCN96 COLORECTAL CANCER SCREENING: COST-EFFECTIVENESS OF CT COLONOGRAPHY

Suchergebnisse filtern